Serum Zinc Concentration and Sarcopenia: A Close Linkage in Chronic Liver Diseases

Journal of Clinical Medicine

Hiroko Iijima¹  Hirayuki Enomoto¹  Naoto Ikeda¹  Kyohei Kishino¹  Ryo Takata¹  Noriko Ishii¹  Nobuhiro Aizawa¹  Hiroki Nishikawa¹  Kazunori Yoh¹  Yukihisa Yuri¹  Yoshiyuki Sakai¹  Yoshinori Iwata¹  Takashi Nishimura¹  Tomoyuki Takashima¹  Kunihiro Hasegawa¹  Shuhei Nishiguchi¹ 

[1] Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya 663-8501, Hyogo, Japan;

关键词: chronic liver disease;    zinc;    sarcopenia;    pre-sarcopenia;    liver cirrhosis;   

DOI  :  10.3390/jcm8030336

来源: DOAJ

【 摘 要 】

We sought to investigate the influence of serum zinc (Zn) concentration on sarcopenia in chronic liver diseases (CLDs, n = 372, median age = 65 years, 147 liver cirrhosis (LC) cases (39.5%)). Sarcopenia was defined by low grip strength and low skeletal muscle mass. Study subjects were divided into the following three groups (High-, Intermediate-, and Low-Zn groups) based on the baseline serum Zn level. The impacts of serum Zn concentration on sarcopenia were examined. The median (interquartile range) serum Zn concentration for all cases was 72.85 (63.7, 81.45) μg/dL. The proportions of sarcopenia in the High-Zn, Intermediate-Zn, and Low-Zn groups were 10.75% (10/93), 11.23% (21/187), and 27.17% (25/92), respectively (P = 0.9046 (High vs. Intermediate), P = 0.0007 (Intermediate vs. Low), P = 0.0044 (High vs. Low), overall P value = 0.0009). The median serum Zn concentrations in patients with sarcopenia, pre-sarcopenia, and control were 66.35, 73.1 and 73.8 μg/dL, respectively (P = 0.0234 (sarcopenia vs. pre-sarcopenia), P = 0.2116 (pre-sarcopenia vs. control), P = 0.0002 (sarcopenia vs. control), overall P value = 0.0016). In the multivariate analyses of factors linked to the presence of sarcopenia, Low-Zn was an independent predictor for all cases (P = 0.0236) and LC cases (P = 0.0082). In conclusion, Zn deficiency can be an independent predictor for sarcopenia in patients with CLDs.

【 授权许可】

Unknown